Login / Signup

Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage.

Chi-Hung LiuYi-Ling WuChih-Cheng HsuTsong-Hai Lee
Published in: Stroke (2023)
Early resumption of antiplatelet was as safe as delayed antiplatelet resumption in ICH patients. Besides, those without prior cerebrovascular disease or with chronic kidney disease may benefit more from early antiplatelet resumption.
Keyphrases
  • prognostic factors
  • chronic kidney disease
  • end stage renal disease
  • risk assessment
  • ejection fraction
  • newly diagnosed
  • climate change